Press Releases from Affiris (5 total)
Parkinson's Vaccine – Top Experts Unite in European Consortium
EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy. AFFiRiS leads consortium.
An international consortium of top European research teams has received…
AFFiRiS - MIG-FONDS INCREASES INVESTMENT BY EURO 3 MILLION
Vienna, 25 September 2008. The successful progress of several vaccine programmes run by AFFiRiS GmbH has prompted investor MIG AG to increase its investment in…
AFFIRIS IN BIOTECH SPOTLIGHT 2008 - INDEPENDENT ANALYSIS CONFIRMS GLOBAL POTENTI …
Vienna, Austria, 28 April 2008: According to an analysis carried out by Lifescience-online, due to it\'s AFFITOME technology AFFiRiS GmbH could become a major player…
AFFIRIS DEVELOPS ALZHEIMER'S VACCINE
Vienna, 17. April 2008. The Viennese biotech company Affiris is today taking stock of the progress achieved to date in its clinical Alzheimer's vaccination programme.…
Affiris begins clinical testing of Alzheimer's vaccine
Vienna, 19th July 2007. The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory…
Go To Page:
